| Primary information |
|---|
| ID | 1546 |
| Peptide Name | CII(256-276, N263, D266) |
| Sequence | GEBGIAGFKGEQGPKGEBGA |
| Length | 21 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Nature | Protein Derived |
| Source of Origin | Type II Collagen |
| Target | Spleen and Lymph node |
| Mechanism of Action | Produce large amount of IL-4. |
| In vitro/In vivo | in vivo |
| Cell Line | None |
| Inhibition Concentartion | NA |
| In vivo Model | HLA-DR1 Transgenic mice, C57BL/6 IL-4 knockout mice |
| Assay | Class II binding assay, ELISA |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | 12483744 |
| Year of Publication | 2002 |
| 3-D Structure | NA |
